Boni E. Elewski MD, FAAD
Chair, Department of Dermatology, and James Elder Professor of Graduate Medical Education, University of Alabama at Birmingham, Birmingham, AlabamaDr. Boni Elewski, an Ohio native, started her career at Ohio State University College of Medicine, where she earned her medical degree. She completed an internship in internal medicine and residency in dermatology at University of North Carolina Memorial Hospital, and she held faculty positions at Northeastern Ohio University College of Medicine and Case Western Reserve School of Medicine, before joining UAB faculty in 1999. Currently, Dr. Elewski serves as the Chair for UAB’s Department of Dermatology where she has been a professor for the past twenty-one years. She holds the James E. Elder M.D. Endowed Professorship for Graduate Education. As an international leader in fungal and psoriasis research and dermatological clinical trials, she has conducted clinical trials through her entire career and has received over 100 clinical trial study grants to pursue therapies for many dermatologic conditions. Dr. Boni Elewski is the author of more than 300 publications and has an esteemed history of serving in numerous national societies and professional organizations, including president of the American Academy of Dermatology from 2004-2005.
Disclosures
Dr. Elewski reports the following:Clinical Research Support - research funding to University
- Abbvie
- Anaptys- Bio
- Boehringer Ingelheim
- Bristol Myers Squibb (BMS)
- Celgene
- Incyte
- Leo
- Lilly
- Merck
- Menlo
- Novartis
- Pfizer
- Regeneron
- UCB
- Sun
- Valeant (Ortho dermatology)
- Vanda
Consultant - received honorarium
- Arcutis
- Boehringer Ingelheim
- BMS
- Celgene
- Leo
- Lilly
- Novartis
- UCB
- Valeant (Ortho dermatology)
Recent Contributions to PracticeUpdate:
- Effect of Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris
- Recommendations for the Treatment of Toenail Onychomycosis
- Tinea Capitis Asymptomatic Carriers: Evidence Behind Treatment
- Efinaconazole 10% Solution for Treatment of Onychomycosis With Longitudinal Spikes
- Limited Effectiveness of Four Oral Antifungal Drugs in the Current Epidemic of Altered Dermatophytosis in India
- Intramuscular Steroids in the Treatment of Dermatologic Disease
- Differences in Trial Design for Topical Treatments of Onychomycosis May Affect Outcomes